Why Axsome Therapeutics Stock Reaches Another High
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
Articles — Page 1526
AbbVie’s Latest Results Reveal Growth Trend Investors Should Watch
AbbVie’s latest results reveal more than a quarterly beat. This article breaks down the growth engines behind the imp...
Lilly Stock Heading $1,000? What Investors Should Know
Investors are watching Eli Lilly as GLP-1 drugs like Mounjaro and Zepbound power growth. This article breaks down the...
Overlooked Stocks Soar 2026: Hidden Winners Ahead in 2026
Smart investors look beyond the loud headlines. This guide explains how overlooked stocks soar 2026 by spotting catal...
Genedx Stock Plummeting Today: Why the Selloff Continues
Biotech stocks can swing wildly on quarterly results and guidance. This article unpacks why genedx stock plummeting t...
Why UnitedHealth Group Stock Came Roaring Back in April
April brought a notable rebound for UnitedHealth Group Stock. This article breaks down the earnings, margin improveme...
Why Rhythm Pharmaceuticals Stock Triumphed on Tuesday
A standout quarterly report helped Rhythm Pharmaceuticals stock surge on Tuesday as investors embraced better-than-ex...
Embecta Stock Plummeted Today: What Investors Need to Know
Embecta faced a sharp decline after its quarterly report, leaving investors wondering about the near-term outlook. Th...
This Millionaire-Maker Biotech Stock: Worth Buying Now?
What could turn a biotech bet into a life-changing gain? This article breaks down how to spot this millionaire-maker ...
Lilly World's Best-Selling Drug: Is the Stock a Buy Now?
Eli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
Cook Reed Hastings Just Redefine Graceful Exits
In 2025, Tim Cook and Reed Hastings stepped back from the helm with quiet discipline, delivering a leadership playboo...
Delta AMEX Pact Fuels Major Growth in Card Rewards
Delta Air Lines and AMEX have renewed their landmark co-brand partnership, reinforcing a revenue engine that has resh...